ML24061A227

ACMUI Notice of Meeting April 8-9 2024

ML24061A227
Person / Time
Issue date:	03/04/2024
From:	Russell Chazell NRC/SECY/RAS
To:
References
FR Citation: 89 FR 16590-16591; 03-07-24
Download: ML24061A227 (1)

Text

[7590-01-P]

NUCLEAR REGULATORY COMMISSION

Advisory Committee on the Medical Uses of Isotopes: Meeting Notice

AGENCY: U.S. Nuclear Regulatory Commission

ACTION: Notice of Meeting.

SUMMARY

The U.S. Nuclear Regulatory Commission (NRC) will convene a meeting of the

Advisory Committee on the Medical Uses of Isotopes (ACMUI) on April 8 - 9, 2024. A sample of

agenda items to be discussed include: a review of recent medical events; a review of

prescription error reduction methods; and a review of several NRC draft licensing guidance

documents for the Eye90 microsphere device, the Akesis Galaxy RTi unit, and the LV Liberty

Vision Y-90 episcleral brachytherapy source. The agenda is subject to change. The current

agenda and any updates will be available on the ACMUIs Meetings and Related Documents

web page at https://www.nrc.gov/reading-rm/doc-c ollections/acmui/meetings/2024.html or by e-

mailing Ms. L. Armstead at the contact information below.

Purpose:

Discuss issues related to 10 CFR Part 35 Medical Use of Byproduct Material.

Date and Time for Open Sessions : April 8, 2024, from 8:30 a.m. to 4:30 p.m. and April 9, 2024,

from 10:00 a.m. to 12:00 p.m. Eastern Standard Time.

Address for Public Meeting: U.S. Nuclear Regulatory Commission, One White Flint North

Building (Commissioners Hearing Room, O1-F 16/O1-G16), 11555 Rockville Pike, Rockville,

Maryland, 20852.

Date Webinar Information (Microsoft Teams)

April 8, 2024 Link: https://teams.microsoft.com/l/meetup-join/19%3ameeting_NjllNmZkO DktZTg3My00MDU0LTk4NzMtNjRhN mJlYmRmNGY1%40thread.v2/0?context=%7b%22Tid%22%3a%22e8 d01475-c3b5-436a-a065-5def4c64f52e%22%2c%22Oid%22%3a%22304f46bf-32c2-4e0f-912c-878db895e74a%22%7d

Meeting ID: 257 264 946 630 Passcode: n3TZmR

Call in number (audio only): +301-576-2978, Silver Spring

Phone Conference ID: 954 210 683#

PUBLIC PARTICIPATION: The meeting will be held in-person and as a webinar using

Microsoft Teams. Any member of the public who wishes to participate in the meeting in person,

via Microsoft Teams, or via phone should contact Ms. L. Armstead using the information below.

Members of the public should also monitor the NRCs Public Meeting Schedule at

https://www.nrc.gov/pmns/mtg for any meeting updates.

CONTACT INFORMATION: Ms. L. Armstead, e-mail: lxa5@nrc.gov, telephone: 301-415-1650.

Conduct of the Meeting

The ACMUI Chair, Hossein Jadvar, M.D., Ph.D., w ill preside over the meeting. Dr. Jadvar will

conduct the meeting in a manner that will facilitate the orderly conduct of business. The

following procedures apply to public participation in the meeting:

1. Persons who wish to provide a written statement should submit an electronic copy to Ms.

L. Armstead using the contact information listed above. All submittals must be received

by the close of business on April 2, 2024, and must only pertain to the topics on the

agenda.

2. Questions and comments from members of the public will be permitted during the

meeting, at the discretion of the ACMUI Chair.

3. The draft transcript and meeting summary will be available on ACMUIs website

https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2024.html on or about

May 24, 2024.

4. Persons who require special services, such as those for the hearing impaired, should

notify Ms. L. Armstead of their planned participation.

This meeting will be held in accordance with the Atomic Energy Act of 1954, as amended

(primarily Section 161a); the Federal Advisory Committee Act (5 U.S.C. App); and the

Commissions regulations in Title 10 of the Code of Federal Regulations, Part 7.

Dated at Rockville, Maryland this 4 th day of March, 2024.

For the U.S. Nuclear Regulatory Commission.

Russell E. Chazell, Federal Advisory Committee Management Officer.